204 related articles for article (PubMed ID: 10068208)
1. Immunophenotypic diagnosis of acute leukemia by using decision tree induction.
Cualing H; Kothari R; Balachander T
Lab Invest; 1999 Feb; 79(2):205-12. PubMed ID: 10068208
[TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
3. Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping.
Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig WD; Gratama JW; Orfao A;
Leukemia; 2007 Jun; 21(6):1204-11. PubMed ID: 17410192
[TBL] [Abstract][Full Text] [Related]
4. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
5. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
Klujber V; Koós R; Schuler D; Bocsi J
Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
[TBL] [Abstract][Full Text] [Related]
6. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
[TBL] [Abstract][Full Text] [Related]
7. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
8. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
9. Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
Kern W; Danhauser-Riedl S; Ratei R; Schnittger S; Schoch C; Kolb HJ; Ludwig WD; Hiddemann W; Haferlach T
Haematologica; 2003 Jun; 88(6):646-53. PubMed ID: 12801840
[TBL] [Abstract][Full Text] [Related]
10. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
[TBL] [Abstract][Full Text] [Related]
12. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
Zelezníková T; Babusíková O
Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
[TBL] [Abstract][Full Text] [Related]
13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
Langebrake C; Brinkmann I; Teigler-Schlegel A; Creutzig U; Griesinger F; Puhlmann U; Reinhardt D
Cytometry B Clin Cytom; 2005 Jan; 63(1):1-9. PubMed ID: 15624201
[TBL] [Abstract][Full Text] [Related]
17. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of haematological neoplasms. General Haematology Task Force of the BCSH.
Clin Lab Haematol; 1996 Dec; 18(4):231-6. PubMed ID: 9054693
[TBL] [Abstract][Full Text] [Related]
18. Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment.
Qadir M; Barcos M; Stewart CC; Sait SN; Ford LA; Baer MR
Cytometry B Clin Cytom; 2006 Sep; 70(5):329-34. PubMed ID: 16739218
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
[TBL] [Abstract][Full Text] [Related]
20. [Immunophenotype analysis in 121 patients with lymphoproliferative diseases by flow cytometry].
Sun XM; Chen JH; Xu JY; Zhang YF; Xie PH; Fan XN; Xie W
Ai Zheng; 2004 Aug; 23(8):955-7. PubMed ID: 15301723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
